glp 1 meds As Interest in GLP-1 Drugs Spikes, Employers Weigh the Costs, Benefits What are GLP-1 medications and
Description
Heres what you need to know about the new research published by The BMJ: How the study was designed Previous studies have suggested that the drugs known as GLP-1s, or glucagon-like peptide-1 receptor agonists, could reduce addictions by targeting the brains reward pathways

Heres a look at the market opportunity
Eur J Drug Metab Pharmacokinet
After its discovery in 1921, its contribution to the pathophysiology of type 2 diabetes mellitus opened a new age in antidiabetic medications and in the study of metabolic diseases

Success depends on consistent daily dosing and proper administration technique

However, its not yet FDA-approved for weight loss